User: Guest

  



DOMAIN EXPERT ENGAGEMENTS

Number of executives repeatedly engaged by snail & email outreach*

POOL + OUTREACH

7883

Interactions with Platform & by Email *

INTERACTIONS

1104

Unique # Participated *

PARTICIPANTS

236

Responses Validated *

VALIDATIONS

45

* Platform engagements are dynamic. Stats are published quarterly.


  •  CODE

  •  PAGES

  •  DATE

  •  PRICE

    $

  •  DATA EXHIBITS

    125


TABLE OF CONTENTS


   Pages :    | $

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Quantitative Techniques & Analytics.....I-3
Product Definitions and Scope of Study.....I-3
  
   A Quick Primer.....II-1
Market Analysis.....II-1
1$110
   Market Dynamics.....II-2
Aging Population Drives Demand.....II-2
Table 1: Select Musculoskeletal Conditions - Percentage Breakdown by Age Group (includes corresponding Graph/Chart).....II-2
1$300
   Table 2: World Demographic Trends: 65+ Group as a Percentage of Total Population by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Latin America for years 2000, 2008, 2010E, and 2020E (includes corresponding Graph/Chart).....II-3
Osteoporosis - Another Demographic Driver.....II-3
Minimally Invasive Procedures Gain Prominence.....II-3
1$300
   Manufacturers Increase Focus on Marketing and Training Programs.....II-4
Technology Advancements to Enhance Penetration.....II-4
PMMA Cement Faces New Challenges.....II-4
1$110
   Vertebral Body Stenting (VBS) - Alternative Technology Advancement.....II-51$110
   The United States.....II-6
Low Back Pain Prevalent in the US.....II-6
Back – Pain : Statistical Insight.....II-6
Aging Population.....II-6
1$110
   Table 3: Percentage of Population in terms of Age Group in the US (includes corresponding Graph/Chart).....II-7

Table 4: Demographics Trends in 65+ Population (includes corresponding Graph/Chart).....II-7
Osteoporosis - A Statistical Review.....II-7
2$300
   Table 5: Osteoporosis Prevalence in Post-Menopause Women (includes corresponding Graph/Chart).....II-9
Europe.....II-9
1$300
   Table 6: European Recent Past, Current & Future Analysis for Vertebral Compression Fracture Devices by Geographic Region - France, Germany, Italy, UK, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....II-101$300
   Table 7: European 10-Year Perspective for Vertebral Compression Fracture Devices by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, and Rest of Europe Markets for Years 2006, 2009 & 2015 (includes corresponding Graph/Chart).....II-11
Asia.....II-11
1$300
   Back Pain – A Warning Signal.....II-12
What Causes Back Pain?.....II-12
2$175
   Precise Cause of Pain: Still Untraceable.....II-14
Spinal Surgery.....II-14
Table 8: Global Spinal Surgery Market (2009 E): Percentage Share Breakdown of Surgical Procedures – Spine Fusion, Bone Graft Substitutes, Disc Replacements, Image Guided Surgery, Vertebroplasty/Kyphoplasty, Nucleus Replacements, and Others (includes corresponding Graph/Chart).....II-14
1$300
   Recuperation After Surgery.....II-15
Novel Innovations Aid in Reduced Pain and Faster Recovery.....II-15
Factors Conducive to Faster Recovery.....II-15
1$110
   Vertebral Compression Fracture.....II-16
Causes Of Vertebral Compression Fracture.....II-16
Osteoporosis.....II-16
Table 9: Osteoporosis - Related Fragility Fractures (includes corresponding Graph/Chart).....II-16
Trauma.....II-16
Pathologic fracture.....II-16
1$300
   Symptoms of Vertebral Compression Fracture.....II-17
Diagnosis.....II-17
Nonsurgical Treatment.....II-17
Self-Healing.....II-17
Bed Rest.....II-17
1$110
   OTC Pain Medicines.....II-18
Bisphosphonates.....II-18
Potential Risks & Complications.....II-18
Chronic Consequences of VCFs.....II-18
Vertebroplasty – Definition.....II-18
1$110
   Patient Benefits.....II-19
Percutaneous Vertebroplasty – A Deeper Insight.....II-19
Patient Selection for Percutaneous Vertebroplasty.....II-19
Kyphoplasty - Definition.....II-19
1$110
   Potential Benefits of Kyphoplasty.....II-20
Adverse Side-Effects.....II-20
Kyphoplasty Versus Vertebroplasty.....II-20
1$110
   Table 10: Vertebroplasty & Kyphoplasty Procedures by Site of Care (includes corresponding Graph/Chart).....II-21
Vesselplasty.....II-21
1$300
   CareFusion Unveils The AVAmax Vertebral Balloon.....II-22
Benvenue Medical Secures CE Mark approval for Kiva™ VCF Treatment System.....II-22
1$110
   Bonesupport Receives EU approval for Cerament Bone Void Filler.....II-23
Bonesupport Secures EU approval for Cerament™ Spine Support.....II-23
1$110
   Alphatec Holdings, Inc. (US).....II-24
ArthroCare Corp (US).....II-24
Biomet, Inc. (US).....II-24
1$110
   Bonesupport AB (Sweden).....II-25
DePuy Spine, Inc. (US).....II-25
Medtronic Sofamor Danek, Inc. (US).....II-25
Kyphon, Inc. (US).....II-25
1$110
   Orthovita Inc. (US).....II-26
Stryker Corporation (US).....II-26
1$110
   Table 11: World Recent Past, Current & Future Market Analysis for Vertebral Compression Fracture Devices by Geographic Region – US, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....II-271$300
   Table 12: World 10-Year Perspective for Vertebral Compression Fracture Devices by Geographic Region – Percentage Breakdown of Dollar Sales for US, Japan, Europe, Asia-Pacific, and Rest of World Markets for Years 2006, 2009 & 2015 (includes corresponding Graph/Chart).....II-281$300
    
 
 


Sales queries: Sales@StrategyR.com
Research queries: Info411@StrategyR.com